CRISPR Therapeutics AG - NAMEN AKT (CRSP)

Q3 2021 13F Holders as of 9/30/2021

Type / Class
Equity / NAMEN AKT
Number of holders
456
Total Shares
40.4M
Shares change
-151K
Total reported value, excl. options
$4.52B
Value change
-$41.1M
Put/Call ratio
1.73
Number of buys
240
Number of sells
-188
Price
$111.93
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.